Status:
COMPLETED
Dexmedetomidine or Hyalase : Which of Them Can Augment Lumbar Epidural Steroid Injection in Failed Back Surgery Patients. A Randomized Clinical Trial
Lead Sponsor:
Minia University
Conditions:
Pain, Chronic
Eligibility:
All Genders
30-75 years
Phase:
EARLY_PHASE1
Brief Summary
hyalase and dexmedtemodine are well known adjuvants given epidurally to alleviate chronic back pain. Use in failed back surgery is an up to date field to hasten analgesia and py off recurrence .
Eligibility Criteria
Inclusion
- Age group. 25-75ys old
- Both sex.
- persistent (at least 6 month) pain and or disability following laminectomy with or without sensory-motor neurological deficits or any form of urinary or bowel incontinence
- Patients suffering from persistent (\> 6 months) back pain following laminectomy for spinal canal stenosis and/or discectomy for herniated nucleus pulposus documented by magnetic resonance imaging (MRI) were included for screening and enrollment.
Exclusion
- Diabetic patients.
- Refusal to participate
- MRI with disc sequestration, concurrent sacro-ilitis, facet arthropathy .
- Coagulopathic patients
- Surgical induced discitis.
Key Trial Info
Start Date :
May 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05370963
Start Date
May 20 2022
End Date
June 1 2023
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maher Maher
ALMinya, Egypt, Egypt, 6115